{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:41:19Z","timestamp":1792611679007,"version":"4.5.0"},"reference-count":19,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0231856","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T17:22:02Z","timestamp":1593451322000},"page":"e0231856","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":38,"title":["Bleeding profile of women using a drospirenone-only pill 4 mg over nine cycles in comparison with desogestrel 0.075 mg"],"prefix":"10.1371","volume":"15","author":[{"given":"S.","family":"Palacios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Colli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9551-2847","authenticated-orcid":true,"given":"P. A.","family":"Regidor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,6,29]]},"reference":[{"issue":"24","key":"pone.0231856.ref001","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa1111840","article-title":"Thrombotic stroke and myocardial infarction with hormonal contraception","volume":"366","author":"\u00d8 Lidegaard","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"pone.0231856.ref002","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.contraception.2015.07.014","article-title":"Drospirenone-only oral contraceptive: results from a multicenter noncomparative trial of efficacy, safety and tolerability","volume":"92","author":"DF Archer","year":"2015","journal-title":"Contraception"},{"issue":"77","key":"pone.0231856.ref003","doi-asserted-by":"crossref","first-page":"34628","DOI":"10.18632\/oncotarget.26015","article-title":"The clinical relevance of progestogens in hormonal contraception: Present status and future developments","volume":"9","author":"PA Regidor","year":"2018","journal-title":"Oncotarget"},{"key":"pone.0231856.ref004","volume-title":"Medical eligibility criteria for contraceptive use","year":"2015","edition":"5"},{"key":"pone.0231856.ref005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2147\/IJWH.S22645","article-title":"Estradiol valerate and dienogest: a new approach to oral contraception","volume":"3","author":"JW Kiley","year":"2011","journal-title":"International journal of women's health"},{"issue":"Suppl. 1","key":"pone.0231856.ref006","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0010-7824(94)90113-9","article-title":"Progestin-only contraception: a comprehensive review","volume":"50","author":"MF McCann","year":"1994","journal-title":"Contraception"},{"issue":"4","key":"pone.0231856.ref007","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/oxfordjournals.humrep.a019245","article-title":"Ovarian activity and vaginal bleeding patterns with a desogestrel-only preparation at three different doses","volume":"11","author":"C Rice","year":"1996","journal-title":"Human Reproduction"},{"key":"pone.0231856.ref008","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0015-0282(16)30062-0","article-title":"Dating the endometrial biopsy","volume":"1","author":"RW Noyes","year":"1950","journal-title":"Fertil Steril"},{"key":"pone.0231856.ref009","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1210\/er.2004-0021","article-title":"Endocrine regulation of menstruation","volume":"27","author":"HN Jabbour","year":"2006","journal-title":"Endocr Rev"},{"key":"pone.0231856.ref010","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10456-005-9003-z","article-title":"Progestogen only contraception and endometrial breakthrough bleeding","volume":"8","author":"OP Smith","year":"2005","journal-title":"Angiogenesis"},{"issue":"Suppl 2","key":"pone.0231856.ref011","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/humrep\/11.suppl_2.20","article-title":"Progestogen-only pills and bleeding disturbances","volume":"11","author":"G. Kovacs","year":"1996","journal-title":"Hum Reprod"},{"key":"pone.0231856.ref012","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/13625189809167250","article-title":"A double-blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen only pills containing desogestrel 75 \u03bcg\/day or levonorgestrel 30 \u03bcg\/day","volume":"3","author":"Collaborative Study Group","year":"1998","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"pone.0231856.ref013","first-page":"43","article-title":"Unscheduled bleeding and contraceptive choice: increasing satisfaction and continuation rates","volume":"7","author":"J Villavicencio","year":"2016","journal-title":"Open Access Journal of Contraception"},{"issue":"4","key":"pone.0231856.ref014","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.contraception.2007.06.008","article-title":"Contraceptive discontinuation attributed to method dissatisfaction in the United States","volume":"76","author":"C Moreau","year":"2007","journal-title":"Contraception"},{"issue":"5","key":"pone.0231856.ref015","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.contraception.2011.01.021","article-title":"Contraceptive failure in the United States","volume":"83","author":"J. Trussell","year":"2011","journal-title":"Contraception"},{"issue":"4","key":"pone.0231856.ref016","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.contraception.2015.12.007","article-title":"Maintenance of ovulation inhibition with a new progestogen-only pill containing drospirenone after scheduled 24-h delays in pill intake","volume":"93","author":"IJM Duijkers","year":"2016","journal-title":"Contraception"},{"issue":"6","key":"pone.0231856.ref017","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/13625187.2015.1044082","article-title":"A randomised study comparing the effect on ovarian activity of a progestogen-only pill (POP) containing desogestrel and a new POP containing drospirenone in a 24\/4 regimen","volume":"20","author":"IJ Duijkers","year":"2015","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"7","key":"pone.0231856.ref018","first-page":"CD004695","article-title":"Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception","author":"A Edelman","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"pone.0231856.ref019","unstructured":"Healthcare Bayer. Yaz Summary of Product Characteristics; 2015."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0231856","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T17:22:18Z","timestamp":1593451338000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0231856"}},"subtitle":[],"editor":[{"given":"Stephen L.","family":"Atkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,6,29]]},"references-count":19,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0231856","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,29]]}}}